Your browser doesn't support javascript.
loading
Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.
Guerci, B; Charbonnel, B; Gourdy, P; Hadjadj, S; Hanaire, H; Marre, M; Vergès, B.
Affiliation
  • Guerci B; Department of endocrinology, diabetology, and nutrition, Brabois hospital and university of Lorraine, 54500 Vandœuvre-lès-Nancy, France. Electronic address: b.guerci@chu-nancy.fr.
  • Charbonnel B; Department of endocrinology, university of Nantes, 44000 Nantes, France.
  • Gourdy P; Department of diabetology, metabolic diseases and nutrition, Toulouse university hospital, 31059 Toulouse, France.
  • Hadjadj S; Department of diabetology, Poitiers university hospital, 86000 Poitiers, France.
  • Hanaire H; Department of diabetology, metabolic diseases and nutrition, Toulouse university hospital, 31059 Toulouse, France.
  • Marre M; Department of diabetology, endocrinology and nutrition, Bichat hospital, AP-HP, 75018 Paris, France.
  • Vergès B; Department of endocrinology-diabetology, University Hospital, 14 rue Gaffarel, 21000 Dijon, France.
Diabetes Metab ; 45(6): 528-535, 2019 12.
Article in En | MEDLINE | ID: mdl-30677504

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Medication Adherence / Glucagon-Like Peptide-1 Receptor / Hypoglycemic Agents Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: Diabetes Metab Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Medication Adherence / Glucagon-Like Peptide-1 Receptor / Hypoglycemic Agents Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: Diabetes Metab Year: 2019 Document type: Article